Concepedia
Statistics
Publications
10
Citations
1.1K
H-Index
Active since
2007
Affiliations
Baylor College of Medicine(Current)
Texas Children's Hospital
Houston Methodist
Methodist Hospital
Bellicum Pharmaceuticals (United States)
An Lu is an author at Baylor College of Medicine specializing in immunotherapy, life sciences, and immunology.
Publications per year
2007–2024
Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
John Craddock, An Lu, Adham S. Bear et al. · Journal of Immunotherapy · 2010 · 502 citations · Full text
Life Sciences, Immunology, Oncology +17
Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor
Aaron E. Foster, Gianpietro Dotti, An Lu et al. · Journal of Immunotherapy · 2008 · 211 citations · Full text
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
Aaron E. Foster, Aruna Mahendravada, Nicholas Shinners et al. · Molecular Therapy · 2017 · 106 citations · Full text
Two-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches
MyLinh T. Duong, Matthew R. Collinson-Pautz, Éva Morschl et al. · Molecular Therapy — Oncolytics · 2018 · 83 citations · Full text
Life Sciences, Immunology, Pharmacology +17
Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies
Matthew R. Collinson-Pautz, Wei-Chun Chang, An Lu et al. · Leukemia · 2019 · 80 citations · Full text
1–5 of 10